F522-0293 Screening compound: N~1~-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(1-methyl-1H-pyrazol-4-yl)-3,6-dihydro-1(2H)-pyridinyl]acetamide

F522-0293 Screening compound: N~1~-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(1-methyl-1H-pyrazol-4-yl)-3,6-dihydro-1(2H)-pyridinyl]acetamide
F522-0293 Screening compound: N~1~-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(1-methyl-1H-pyrazol-4-yl)-3,6-dihydro-1(2H)-pyridinyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F522-0293
N~1~-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(1-methyl-1H-pyrazol-4-yl)-3,6-dihydro-1(2H)-pyridinyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F522-0293

Molecular Formula

C19H22N4O3 (C19 H22 N4 O3)

Compound Name

N~1~-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(1-methyl-1H-pyrazol-4-yl)-3,6-dihydro-1(2H)-pyridinyl]acetamide

IUPAC name

n/a

SMILES

Cn1ncc(C2=CCN(CC(Nc(cc3)cc4c3OCCO4)=O)CC2)c1

InChI

InChI=1S/C19H22N4O3/c1-22-12-15(11-20-22)14-4-6-23(7-5-14)13-19(24)21-16-2-3-17-18(10-16)26-9-8-25-17/h2-4,10-12H,5-9,13H2,1H3,(H,21,24)

InChI Key

HCMMFBIWONNLMK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27171969

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

354.41

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.465

Distribution Coefficient, logD

1.465

Water Solubility, LogSw

-2.29

Polar Surface Area

57.481

Acid Dissociation Constant (pKa)

10.46

Base Dissociation Constant (pKb)

2.62

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.80

F522-0293 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F522-0293 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F522-0293?
Check Price and Availability of F522-0293, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F522-0293 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F522-0293
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F522-0293
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F522-0293 available by request